BriaCell Appoints Immunology Expert, Dr. Cara L. Haymaker, to Scientific Advisory Board; BriaCell CEO to Lead Special ‘Targeted Immunotherapy’ Issue in Prestigious Journals

Ads

You May Also Like

Orion has started a Phase III trial to develop a drug for ALS – The patient recruitment has begun

ORION CORPORATION                                                                         PRESS RELEASE                                                                         6 JULY 2018 AT 11.00 EEST             Orion has ...